Претраживање
Приказ резултата 1-10 од 190
Evaluation of ACE inhibitors lipophilicity using in silico and chromatographically obtained hydrophobicity parameters / Procena lipofilnosti ACE inhibitora primenom in silico i hromatografski dobijenih parametara hidrofobnosti
(Savez hemijskih inženjera, Beograd, 2013)
The aim of this study was to compare different calculation methods to determine the lipophilicity, expressed as log P value, of seven ACE inhibitors (enalapril, quinapril, fosinopril, lisinopril, cilazapril, ramipril and ...
Correlation of N-terminal pro-B-type natriuretic peptide with clinical parameters in patients with hypertension
(Vojnomedicinska akademija - Institut za naučne informacije, Beograd, 2013)
Background/Aim. Identification of patients with arterial hypertension and a possible onset of heart failure by determining the concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP) enables timely intensification ...
Analysis of regulatory-ethical framework of clinical trials / Analiza razvoja regulatorno-etičkog okvira za klinička ispitivanja
(Srpsko lekarsko društvo, Beograd, 2013)
Introduction. Every clinical trial has to meet all ethical criteria in addition to the scientific ones. The basic ethical principles in the clinical trials are the following: nonmaleficence, beneficence, respect for autonomy ...
Pharmaceutical care in the treatment of deep vein thrombosis / Farmaceutska zdravstvena zaštita u terapiji duboke venske tromboze
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Anticoagulation therapy is commonly used in deep vein thrombosis (DVT) prophylaxis associated with surgical interventions and in treatment of patients with DVT, atrial fibrillation and prosthetic heart valves. Long-term ...
Over-expressed CmbT multidrug resistance transporter improves the fitness of Lactococcus lactis / Uticaj povećane ekspresije CmbT MDR transportera na rast Lactococcus lactis
(Društvo genetičara Srbije, Beograd, 2013)
The influence of the over-expression of CmbT multidrug resistance transporter on the growth rate of Lactococcus lactis NZ9000 was studied. L. lactis is a lactic acid bacteria (LAB) widely used as a starter culture in dairy ...
Nanomaterials in cosmetic products: Functionality and safety issues / Nanomaterijali u kozmetičkim proizvodima - opravdanost primene i bezbednost
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Nanomaterials in cosmetic products include particles of active ingredients (AI) (nanocrystals, nanoparticles) (e.g., ultrafine/nanoparticles titanium dioxide, zinc oxide, silver, gold) as well as a variety of nanocarriers ...
Distribution of Low-Density Lipoprotein and High-Density Lipoprotein Subclasses in Patients With Sarcoidosis
(Coll Amer Pathologists, Northfield, 2013)
Context.-Systemic inflammatory diseases are associated with proatherogenic lipoprotein profile, but there is a lack of information regarding overall distributions of lipoprotein subclasses in sarcoidosis. Objective.-To ...
Motivation of students' population blood donors at the University of Belgrade: Faculty of Pharmacy / Motivisanost studenata davalaca krvi na Farmaceutskom fakultetu Univerziteta u Beogradu
(Institut za transfuziju krvi Srbije, Beograd, 2013)
Introduction: Insufficient blood donation is almost generally recognized as a world-wide problem being followed by a trend in an ever decreasing number of collected blood units. Aims: (i) Analysis of voluntary blood donation ...
Evaluation of DNA damage in the lymphocytes of young, elderly and Alzheimer's disease patients treated with β-estradiol in the comet assay / Evaluacija oštećenja DNK u limfocitima mladih, starih i pacijenata obolelih od Alchajmerove bolesti tretiranih β-estradiolom u komet testu
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2013)
Background: The antioxidant activity of estrogen has a beneficial impact in Alzheimer's disease. A variety of clinical studies have demonstrated that estrogen replacement therapy in postmenopausal women results in a lower ...
Evaluation of pharmacists' knowledge and attitudes regarding rare diseases and orphan drugs / Procena znanja i stavova farmaceuta o retkim bolestima i lekovima za retke bolesti
(Univerzitet u Nišu - Medicinski fakultet, Niš, 2013)
Rare diseases (RD) are very heterogenic group of disorders affecting less than 5 out of 10.000 people in the European Union (EU), at the same time putting them in danger or disabling them chronically. It is estimated that ...